Standard versus reduced-dose chemoradiotherapy in anal cancer (PLATO-ACT4): short-term results of a phase 2 randomised controlled trial.
Gilbert A, Adams R, Webster J, Gilbert DC, Abbott NL, Berkman L, Bottomley D, Brown SR, Casanova N, Copeland J, Falk S, Glynne-Jones R, Goh V, Hawkins MA, Khan S, Muirhead R, Rao S, Renehan AG, Richman SD, Ruddock S, Smith A, Stewart AJ, Whibley M, Wood HM, Sebag-Montefiore D, Harrison M; PLATO trial study group.
Gilbert A, et al.
Lancet Oncol. 2025 Jun;26(6):707-718. doi: 10.1016/S1470-2045(25)00213-X. Epub 2025 May 4.
Lancet Oncol. 2025.
PMID: 40334666
Free article.
Clinical Trial.